Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Arts and Humanities

Faculty of Health and Behavioural Sciences - Papers (Archive)

2009

Cancer

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Does Presentation Make A Difference To Risk Perception: Testing Different Formats For Communication Of Cancer Risks, Sandra C. Jones Jan 2009

Does Presentation Make A Difference To Risk Perception: Testing Different Formats For Communication Of Cancer Risks, Sandra C. Jones

Faculty of Health and Behavioural Sciences - Papers (Archive)

Evidence suggests that the presentation format of risk information can affect people’s perceptions of risk and influence health-related decisions. In these studies we investigated the impact of four different risk presentation formats: standard presentation, risk ladder, different base rates and visual representations on women’s perceptions of developing breast cancer of lymphoma. We found that the different presentations had virtually no impact on the participant’s risk estimates. Only in the second study relating to risk perceptions for lymphoma was there a significant difference between conditions for estimated 10-year-risk, with those in the ladder present condition reporting a lower estimated risk. The …


Multiple Myeloma; Clinical Update On A Rare And Treatable Cancer, Moira Stephens Jan 2009

Multiple Myeloma; Clinical Update On A Rare And Treatable Cancer, Moira Stephens

Faculty of Health and Behavioural Sciences - Papers (Archive)

Multiple myeloma is a rare cancer, contributing 1% of cancers and 15% of haematological malignancies. Myeloma is an incurable, yet increasingly treatable cancer with people often living in a chronic (controlled) state of relapse, i.e. living with a low level of disease for many years. Survival with myeloma varies from a few months to decades. Nurses play a valuable role in caring for people with myeloma and with their specialist knowledge of the pathophysiology of myeloma and the effects of treatment, together with their therapeutic relationship with the patient and the family, are in an important position to influence care …